| Name | 5-[3-(1-methylcyclopropyl)propyl]-1H-pyrano[2,3-d]pyrimidine-2,4,7-trione |
|---|---|
| Synonyms | unii-g2283xq6vj |
| Description | SCH-900271 is an orally active, potent nicotinic acid receptor (NAR) agonist with an EC50 of 2 nM in the hu-GPR109a assay. SCH-900271 exhibits dose-dependent inhibition of plasma free fatty acid (FFA). SCH-900271 has an improved therapeutic window to flushing[1]. |
|---|---|
| Related Catalog | |
| Target |
EC50: 2.0 nM (hu-GPR109a), 96 nM (hu-GPR109b), 8.0 nM (rat-GPR109a), 6.0 nM (m-GPR109a) and 5.0 nM (dog-GPR109a)[1] |
| References |
| Molecular Formula | C14H16N2O4 |
|---|---|
| Molecular Weight | 276.28800 |
| Exact Mass | 276.11100 |
| PSA | 96.45000 |
| LogP | 2.11700 |